mobile header
Dr. Hemant Rathore

Dr. Hemant Rathore american Oncology Hospitals

Dr. Hemant Rathore

Consultant - Nuclear Medicine

Book an Appointment
Share Profile share

Dr. Hemant Rathore is an experienced Nuclear Medicine physician in Kota with 13+ years of overall experience and 8+ years of specialized experience in Nuclear Medicine. He has extensive expertise in advanced molecular imaging, PET/CT and SPECT imaging, as well as radionuclide therapies for cancer and other complex conditions.Currently he is serving as a Consultant - Nuclear Medicine at American Oncology Institute, Kota.

He completed his MBBS from R.D. Gardi Medical College, Ujjain, and DNB in Nuclear Medicine from Jaslok Hospital and Research Centre, Mumbai. He has also pursued a Fellowship in Asian Nuclear Medicine Board (FANMB), Seoul, South Korea, and is a qualified Radiation Safety Officer (RSO II & III) trained through BARC. His international exposure includes advanced training and observership in Molecular Imaging and Nuclear Medicine Therapies in California, USA.

Prior to joining AOI Kota, Dr. Rathore served as Consultant and Head of the Department of Nuclear Medicine & PET/CT at Bombay Hospital and Medical Research Centre, Mumbai, along with earlier roles at Jaslok Hospital and Research Centre, Mumbai, and Bhagwan Mahaveer Cancer Research Centre, Jaipur.

  • Consultant and Head - Nuclear Medicine & PET CT, Bombay Hospital and Medical Research Centre, Mumbai, Jan 2020 - July 2026
  • Associate Consultant - Nuclear Medicine, Bhagwan Mahaveer Cancer Research Centre, Jaipur, Apr 2019–Nov 2019
  • Senior Resident - Nuclear Medicine, Jaslok Hospital and Research Centre, Mumbai, Dec 2018–Dec 2019
  • Junior Resident - Nuclear Medicine, Jaslok Hospital and Research Centre, Mumbai, Sep 2014–Oct 2017
  • Chief Medical Officer, Sant Parmanand Hospital, New Delhi, Mar 2014–Aug 2014
  • Resident Medical Officer - Neurosurgery, Choithram Hospital, Indore, Nov 2013–Mar 2014
  • Internship, C.R. Gardi Hospital, Ujjain, Madhya Pradesh, Dec 2011–Dec 2012
  • MBBS, R.D. Gardi Medical College, Ujjain, 2011
  • DNB - Nuclear Medicine, Jaslok Hospital, Mumbai,2018
  • Qualified Radiation Safety Officer (RSO II & III), BARC, Mumbai, 2018
  • Fellowship in Palliative Care (U.K.), 2022
  • Fellowship in Asian Nuclear Medicine Board (FANMB), Seoul, South Korea, 2023
  • Observership & Training in Molecular Imaging and Nuclear Medicine Therapies, California, USA, 2025
  • Certification Course in Management of Thyroid Disorders (CCMTD)
  • Clinical Care Program Certification (CCPC)
  • PET/CT & Advanced Nuclear Imaging
  • Prostate & Neuroendocrine Cancers – PSMA and DOTATATE PET/CT imaging and targeted therapies
  • Targeted Radionuclide Therapy – Lutetium-PSMA and Lutetium-DOTATATE therapies for advanced cancers
  • Thyroid Disorders & Cancer – Radioactive Iodine Therapy for thyroid cancer and Graves’ disease
  • PET/CT-guided biopsy
  • Brain & Cardiac Imaging – Nuclear imaging for neurological disorders, Parkinsonism and cardiac assessment

7 peer-reviewed publications, including:

  • Indian J Nucl Med (2022–2023) — 4 papers on FDG-PET/CT in tuberculosis, limbic encephalitis, Pneumocystis jiroveci pneumonia, and CIDP/plasmacytoma
  • Bombay Hospital Journal (2021) — Creutzfeldt-Jakob Disease & CMV Colitis case reports
  • The Indian Practitioner (2022) — FDG PET/CT in Pulmonary PEComa
  • Thesis: "177-Lutetium PSMA Therapy in Patients with Metastatic Castration Resistant Prostatic Cancers: Assessment of Response, Clinical Evaluation, Toxicity" (Jaslok Hospital, 2014–2016)
  • RSNA Best Resident Research Award, 2017 – Chicago, USA, for pioneering research on Lutetium-PSMA therapy for advanced prostate cancer
  • Received State Award by Governor of Rajasthan, 2020
  • Received Late Shri Murli Deora Award, Mumbai, 2018
  • District Collector's Award, Baran for Contribution to Medicine and Medical Research, Rajasthan, 2016
  • Presented research at major international forums including RSNA and EANM in the USA and Europe
  • Represented India at International IPPNW World Congress including Kazakhstan 2014, York 2017, Nagasaki 2025
  • Recieved Best Speaker Award, Jaslok Hospital, 2016

RMC No. 33207